RENU OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
ReNu is a cryopreserved amniotic suspension allograft (ASA) containing micronized amniotic membrane & amniotic fluid cells. Read more about ReNu Osteoarthritis
MM-II OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
MM-II is a new non-opioid intra-articular injection designed to alleviate knee pain in patients with osteoarthritis. Get more insights into our latest reports
LORECIVIVINT OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
Lorecivivint (SM04690) is a small-molecule inhibitor targeting the Wnt pathway, delivered through intra-articular injection. Get more insights into our reports
INVOSSA OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
INVOSSA is a groundbreaking cell and gene therapy designed to treat knee osteoarthritis with a single intra-articular injection. Request Free Sample Report
LNA043 OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
LNA043 is an innovative ANGPTL3 agonist designed to specifically target and repair damaged cartilage. Read more about LNA043 Osteoarthritis pipeline report